c-erbB-2 amplification in mammary carcinoma
- 1 January 1993
- journal article
- research article
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 53 (S17G) , 132-138
- https://doi.org/10.1002/jcb.240531126
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- A novel transcription factor, OB2-1, is required for overexpression of the proto-oncogene c-erbB-2 in mammary tumour lines.The EMBO Journal, 1993
- Overexpression of the c-erbB-2 oncoprotein: Why does this occur more frequently in ductal carcinoma in situ than in invasive mammary carcinoma and is this of prognostic significance?European Journal Of Cancer, 1992
- c-erbB-2 oncoprotein expression in primary and advanced breast cancerBritish Journal of Cancer, 1991
- Immunohistochemical demonstration of c-erbB-2 protein in mammary ductal carcinoma in situHuman Pathology, 1990
- An immunohistochemical study of the presence of c‐erbB‐2 protein in Paget's disease of the nippleHistopathology, 1989
- An immunohistochemical evaluation of c-erbB-2 expression in human breast carcinomaBritish Journal of Cancer, 1988
- Expression of the c‐erbB‐2 protein in normal and transformed cellsInternational Journal of Cancer, 1987
- OVEREXPRESSION OF THE c-erbB-2 ONCOPROTEIN IN HUMAN BREAST CARCINOMAS: IMMUNOHISTOLOGICAL ASSESSMENT CORRELATES WITH GENE AMPLIFICATIONThe Lancet, 1987
- Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu OncogeneScience, 1987
- Assessment of response to therapy in advanced breast cancerPublished by Elsevier ,1977